ClinicalTrials.gg
Drug

Insulin Aspart clinical trials

Also written NovoRapid, Novolog, NN1218 and Aspart.

studies test it
207
open now
8
in phase 3
60
first study started
1997

Counted the way a researcher would: Insulin Aspart with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Insulin Aspart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Insulin Aspart studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Jun 2000 · NOVOLOG PENFILL · BLA 020986 (FDA, Drugs@FDA)
European Union
7 Sept 1999 · NovoRapid · EMEA/H/C/000258 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

insulin aspart
93
biphasic insulin aspart
27
Faster-acting insulin aspart
20
biphasic insulin aspart 50
13
biphasic insulin aspart 70
10

Brand

NovoRapid
17
Novolog
11
Fiasp
5

Development codes

NN1218
6
I004
2
GP40071
1

Other names

Aspart
4
Aspart insulin
4

In one entry with another drug

Given together, or one or the other

insulin degludec/insulin aspart
8
Insulin Degludec and Insulin Aspart
2
Insulin Degludec and Insulin Aspart Injection
2

Studies by the year they started

205 studies that test it; most in 2003 (16)

Studies that test Insulin Aspart, by start year
YearStudies
19971
19981
19994
20004
20014
200215
200316
200416
200512
20068
200713
20089
20091
20108
201110
20124
201310
201411
20159
201610
20172
20186
20198
20203
20214
20225
20236
20242
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
55
Phase 2
10
Phase 3
60
Phase 4
64
No phase
20

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 142 · Other 65

Novo Nordisk A/S (125) · Medical University of Warsaw (4) · Anna Stanhewicz, PhD (3) · Emory University (3) · Sanofi (3) · Rush University Medical Center (3) · Medical University of Graz (3) · Amphastar Pharmaceuticals, Inc. (2)

Often tested with

Tested in the same studies.

Insulin Detemir (20) · Insulin degludec (18) · Insulin Glargine (17) · Insulin Lispro (14) · Insulin glulisine (10) · Insulin, Regular, Human (9) · Metformin (9) · Insulin aspart, insulin aspart protamine drug combination 30:70 (8)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test Insulin Aspart.

Studies

Open first, then newest update. How each study uses Insulin Aspart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 207

See all 207 studies that test Insulin Aspart →

Given beside what is tested · 78 — Insulin Aspart is usual care or a partner of the new treatment

Showing 20 of 78.

As the comparator · 44 — what is tested is compared with Insulin Aspart

Showing 20 of 44.

Codes

What other systems call Insulin Aspart · ClinicalTrials.gg INT008948

  • MeSH (NLM) D061267Insulin AspartConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) D933668QVXINSULIN ASPARTConfirmed FDA, NLM
  • RxNorm 51428One source FDA
  • NCI Thesaurus C47563Insulin AspartOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.